Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Effect of DLPFC Targeted rTMS on Phantom Limb Pain and Associated Psychological Comorbidities: A Pilot Randomized Controlled Trial.

Created on 25 Aug 2026

Authors

Deepanshu Vats, Renu Bhatia, Sushma Sagar, Aasheesh Kumar, Raj Kumar Yadav, Maroof Ahmad Khan, Sheffali Gulati, Akanksha Singh

Published in

Neurorehabilitation and neural repair. Pages 15459683261477087. Aug 25, 2026. Epub Aug 25, 2026.

Abstract

Maladaptive cortical plasticity is central to the pathophysiology of phantom limb pain (PLP), a condition often accompanied by sleep disturbances, anxiety, and depression states affecting quality of life. Repetitive transcranial magnetic stimulation (rTMS) has potential for relieving chronic neuropathic pain. Dorsolateral prefrontal cortex (DLPFC) is a critical component of neural circuitry subserving pain processing and associated affective aspects of pain. rTMS induced neuromodulation of DLPFC could be a potential therapeutic strategy in PLP management. Present study explored the role of rTMS of DLPFC on pain, anxiety, depression, and quality of life in PLP patients.
Twenty-seven traumatic amputees with PLP were randomized into real or sham rTMS group. Real rTMS therapy included 10 sessions over 2 weeks, with 1Hz stimulation at 90% resting motor threshold applied to DLPFC contralateral to amputation site. For sham rTMS therapy, same protocol was used, except coil was placed perpendicular to the scalp, preventing actual stimulation. The primary outcome was pain intensity assessed using Visual Analogue Scale. Secondary outcomes included pain assessment using Short-Form McGill Pain Questionnaire, anxiety using Hamilton Anxiety Rating Scale, depression using Hamilton Depression Rating Scale, and quality of life using WHO quality of life-BREF questionnaire. Assessments were performed at baseline, after 10th session, and during follow-up on days 15, 30, and 60 post-therapy.
rTMS on DLPFC was associated with improvement in PLP, anxiety, depression, and quality of life. The findings suggest the potential of DLPFC-rTMS as an adjunctive modality in the management of PLP.

PMID:
42638615
Bibliographic data and abstract were imported from PubMed on 25 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement